.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,601,838

« Back to Dashboard

Claims for Patent: 5,601,838

Title: Method for treating pain associated with herpes-zoster and post-herpetic neuralgia
Abstract:A method is offered for reducing the pain associated with herpes-zoster and post-herpetic neuralgia. The method consists of administering a composition incorporating a transdermal delivery system for the administration of Lidocaine to areas of the body afflicted by herpes-zoster and post-herpetic neuralgia enclosed with an occlusive dressing or a plaster dressing.
Inventor(s): Hind; Harry (Los Altos, CA)
Assignee: Hind Health Care, Inc. (Los Altos, CA)
Application Number:07/526,771
Patent Claims: 1. A method for reducing pain associated with herpes-zoster and post-herpetic neuralgia, said method comprising:

applying at the site of pain:

(1) a composition comprising lidocaine in a physiologically acceptable vehicle capable of transdermal penetration for a time sufficient for said lidocaine to be transported across said skin to the site of pain involvement in an amount sufficient to relieve said pain, said vehicle comprising from 1-20 weight percent lidocaine, and;

(2) an occlusive dressing of a physiologically acceptable plastic film;

whereby extended pain relief is obtained substantially after said applying and after any anesthetic effect of such lidocaine is terminated.

2. A method according to claim 1, wherein said occlusive dressing Saran Wrap, polyethylene film, or polyvinyl and is impermeable to the composition.

3. A method according to claim 1, wherein said dressing is a plaster dressing wherein said lidocaine is incorporated into the adhesive layer of said plaster.

4. A method for reducing pain associated with herpes-zoster and post-herpetic neuralgia for extended periods of time, said method comprising:

a. applying to the skin at the site of pain a composition comprising lidocaine in a concentration of about 5-15% in a physiologically acceptable vehicle capable of transdermal penetration for a time sufficient for said lidocaine to be transported across said skin to the site of involvement in an amount sufficient to relieve pain, said vehicle comprising: a glycol in about 75-85%; a nonionic surfactant in about 2-20%; and a thickening agent in about 0.1-5%; and

b. covering the composition with a plastic film as an occlusive dressing or as a plaster dressing simultaneously or consecutively with said applying;

whereby extended pain relief is obtained substantially after said applying and after any anesthetic effect of said lidocaine is terminated.

5. A method for reducing pain associated with herpes-zoster and post herpetic neuralgia for extended periods of time, said method comprising:

applying to the skin at the site of pain a plaster which comprises a composition which comprises lidocaine as the base form in a concentration of about 1-20 weight % incorporated into the adhesive layer of said plaster.

6. A method for reducing pain associated with herpes-zoster and post-herpetic neuralgia, said method comprising:

applying at the site of pain:

(1) a composition comprising lidocaine in a physiologically acceptable vehicle capable of transdermal penetration for a time sufficient for said lidocaine to be transported across said skin to the site of pain involvement in an amount sufficient to relieve said pain, said vehicle comprising from 1-20 weight percent lidocaine, and;

(2) a plaster dressing wherein said anesthetic is incorporated into the adhesive layer of said plaster;

whereby extended pain relief is obtained substantially after said applying and after any anesthetic effect of such lidocaine is terminated.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc